Do you read CYP announcements?
Usually.
Sometimes I miss details. That has happened before. This doesn't seem to be one of those times though.
I think what you are wanting me to see is - " Final start up activities underway in concert with CRO IQVIA" (CRO - I take as contract research organization)
It seems to me that you have extrapolated, (rather than that Cynata have actually said) from that piece of information, that CRO IQVIA will also be effectively managing the Australian aspects of the trial along with them managing the rest of the world as well.
On the basis of what you show here and what I've read elsewhere I am not willing to assume as you seemed to have done that CYP won't split (for the purposes of costs) the trial into an inside the US component (handled by CRO IQVIA) and an outside the US-component. I think to save money CYP might try to delegate only the US aspects of the trial to the CRO.
- Forums
- ASX - By Stock
- Ann: Two-Year Results of Phase 1 SR-aGvHD Trial Presented at ISCT
CYP
cynata therapeutics limited
Add to My Watchlist
3.13%
!
15.5¢

Do you read CYP announcements?Usually. Sometimes I miss details....
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
15.5¢ |
Change
-0.005(3.13%) |
Mkt cap ! $35.02M |
Open | High | Low | Value | Volume |
16.0¢ | 16.5¢ | 15.5¢ | $22.43K | 139.5K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 58708 | 15.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
16.0¢ | 9763 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 58708 | 0.155 |
5 | 106673 | 0.150 |
2 | 45000 | 0.140 |
1 | 10937 | 0.130 |
1 | 26000 | 0.115 |
Price($) | Vol. | No. |
---|---|---|
0.160 | 9763 | 1 |
0.165 | 38474 | 1 |
0.170 | 70000 | 2 |
0.175 | 77450 | 2 |
0.180 | 62619 | 3 |
Last trade - 16.10pm 26/06/2025 (20 minute delay) ? |
Featured News
CYP (ASX) Chart |
The Watchlist
PTX
PRESCIENT THERAPEUTICS LIMITED
James McDonnell, CEO
James McDonnell
CEO
Previous Video
Next Video
SPONSORED BY The Market Online